Relationship Between 25(OH) D and IGF-I in Children and Adolescents with Growth Hormone Deficiency

被引:20
|
作者
Witkowska-Sedek, E. [1 ]
Kucharska, A. [1 ]
Ruminska, M. [1 ]
Pyrzak, B. [1 ]
机构
[1] Warsaw Med Univ, Dept Pediat & Endocrinol, 63A Zwirki & Wigury St, PL-02091 Warsaw, Poland
来源
关键词
25(OH) D; IGF-I; Growth hormone deficiency; Children; Adolescents; rhGH treatment; VITAMIN-D DEFICIENCY; HEALTHY; CELLS;
D O I
10.1007/5584_2016_212
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies have shown that vitamin D has an impact on the production and secretion of IGF-I in the liver. The aim of our study was to investigate the relationship between the concentrations of 25-hydroxy vitamin D [25 (OH) D] and insulin-like growth factor I (IGF-I) in growth hormone deficient children and adolescents before recombinant human growth hormone (rhGH) treatment. The study was retrospective and included 84 children and adolescents aged 4-17. Prior to initiating rhGH therapy, concentrations of 25(OH) D and IGF-I were measured in all patients. IGF-I concentrations were normalized for bone age. The studied group was divided into two subgroups according to serum 25(OH) D levels. Significant positive correlations between 25(OH) D concentration and IGF-I SDS-normalized for bone age were observed in both studied subgroups. The results of our study suggest that vitamin D deficiency could influence IGF-I concentrations in children and adolescents with growth hormone deficiency, and vitamin D deficiency should be normalized before the measurement of IGF-I concentrations to obtain the reliable and unbiased IGF-I values.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [31] IMPACT OF THE UNDERLYING ETIOLOGY OF GROWTH HORMONE DEFICIENCY ON SERUM IGF-I SDS LEVELS DURING GH TREATMENT IN CHILDREN
    Leger, Juliane
    Mohamed, Damir
    Dos Santos, Sophie
    Ben Azoun, Myriam
    Zenaty, Delphine
    Simon, Dominique
    Paulsen, Anne
    Martinerie, Laetitia
    Chevenne, Didier
    Alberti, Corinne
    Carel, Jean-Claude
    Guilmin-Crepon, Sophie
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 120 - 121
  • [32] Association between the insulin resistance of puberty and the IGF-I/growth hormone axis
    Moran, A
    Jacobs, DR
    Steinberger, J
    Cohen, P
    Hong, CP
    Prineas, R
    Sinaiko, AR
    DIABETES, 2002, 51 : A354 - A355
  • [33] Growth hormone, IGF-I and insulin and their abuse in sport
    Holt, R. I. G.
    Soenksen, P. H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (03) : 542 - 556
  • [34] The growth hormone IGF-I axis in dilated cardiomyopathy
    Jenkins, RC
    Ross, RJM
    CLINICAL ENDOCRINOLOGY, 1999, 50 (04) : 415 - 416
  • [35] Skeletal effects of growth hormone and IGF-I in adults
    Robert Marcus
    Endocrine, 1997, 7 : 53 - 55
  • [36] Interaction between IGF-I, insulin and growth hormone in type II diabetes
    Clemmons, DR
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 : 97 - 104
  • [37] Growth hormone and IGF-I therapy in the hypercatabolic patient
    Wolf, SE
    Barrow, RE
    Herndon, DN
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1996, 10 (03): : 447 - 463
  • [38] The role of growth hormone and IGF-I in the pathogenesis of osteoporosis
    Rosen, OJ
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) : S2 - S3
  • [39] Regulation of muscle mass by growth hormone and IGF-I
    Velloso, C. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (03) : 557 - 568
  • [40] Skeletal effects of growth hormone and IGF-I in adults
    Marcus, R
    HORMONE RESEARCH, 1997, 48 : 60 - 64